Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re bioMSAR Testing at Aquafuel Research Ltd

31 Jan 2022 07:00

RNS Number : 0661A
Quadrise Fuels International PLC
31 January 2022
 

31 January 2022

Quadrise Fuels International plc

("Quadrise" or the "Company")

 

Update re bioMSAR Testing at Aquafuel Research Ltd

 

Quadrise (AIM:QFI)the supplier of MSAR® and bioMSAR™ emulsion technology and fuels, is pleased to confirm the results of the latest bioMSAR™ testing at Aquafuel Research Ltd's ("Aquafuel") UK test facility.

The results relate to further engine optimisation testing of bioMSAR™, conducted on the Company's Cummins high-speed 4-stroke diesel engine generating set, to allow accurate performance monitoring, optimisation and measurements to be made. They follow the initial testing at Aquafuel, the results of which were published by the Company on 1 February 2021. 

During 2021 the engine was modified to allow injection timing to be advanced and performance to be monitored more accurately. These enhancements provided the ability to assess and optimise engine efficiency and emissions whilst using bioMSAR™ and other fuels.

Initial baseline runs under the latest testing were undertaken to ensure prior bioMSAR™ performance results were repeatable. These confirmed previously announced engine efficiency benefits of 3% and reductions of Nitrogen Oxide ("NOx") emissions of over 20% in comparison to diesel fuel.

The next phase of testing now completed has demonstrated that by advancing injection timing, engine efficiency can be increased by over 13%, thereby further reducing fuel consumption and carbon dioxide ("CO2") emissions.

Ordinarily, higher engine efficiencies result in increased combustion temperatures and NOx emissions. However, of particular note, the latest tests at Aquafuel have confirmed that it was possible with bioMSAR™ to reduce the inlet air temperature to the same level as diesel. This resulted in NOx levels being further reduced by over 30%, some 45% lower than diesel fuel.

These latest tests have therefore shown that much higher diesel engine efficiency can be achieved with bioMSAR™, without increasing NOx emissions. Further tests are being planned with Aquafuel during the year to focus on fully defining efficiency and emissions optimisation settings.

Jason Miles, CEO of Quadrise, said:

"We are pleased to obtain these outstanding results for bioMSAR™, providing further technical endorsement of the potential of the fuel. The higher engine efficiency and lower emissions evidenced by Aquafuel's testing are highly attractive features for all future clients of bioMSAR™, particularly those with ambitious decarbonisation targets. These results support our plans for larger-scale bioMSAR™ testing this year, and ultimately commercialisation."

 

For further information, please refer to the Company's website at www.quadrisefuels.com or contact:

 

Quadrise Fuels International Plc

 

Jason Miles, Chief Executive Officer

+44 (0)20 7031 7321

David Scott, Head of Finance

 

Nominated Adviser

 

Cenkos Securities plc

 

Ben Jeynes

+44 (0)20 7397 8900

Katy Birkin

 

 

Broker

Shore Capital Stockbrokers Limited

 

Toby Gibbs

+44 (0)20 7408 4090

Fiona Conroy

 

Public & Investor Relations

 

Vigo Consulting

Patrick D'Ancona

Charlie Neish

+44 (0)20 7390 0230

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBMMJTMTIJTIT
Date   Source Headline
13th Mar 20237:00 amRNSProposed Change of Name
6th Mar 20234:35 pmRNSPrice Monitoring Extension
3rd Mar 20237:00 amRNSWärtsilä Testing Update
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
23rd Feb 20237:00 amRNSMorocco Project Update
1st Feb 20237:00 amRNSBlock Admission Cancellation and Interim Review
31st Jan 20237:00 amRNSAppointment of New Auditor
30th Jan 20237:00 amRNSRe-Issue of Historical Share Options
16th Jan 20237:00 amRNSBusiness Update
29th Nov 20222:23 pmEQSQuadrise Fuels International (QFI): Key role in transitioning to net-zero
25th Nov 20222:16 pmRNSResult of AGM
25th Nov 20227:00 amRNSAGM Statement
23rd Nov 20227:00 amRNSPublication of Sustainability Report
15th Nov 20227:00 amRNSExtension of Exclusive Agreement with Nouryon
28th Oct 20224:48 pmRNSPosting of Annual Report and Notice of AGM
3rd Oct 20227:00 amRNSFinal Results and Notice of AGM
21st Sep 20227:00 amRNSJoint Development Agreement with Vertoro
14th Sep 20227:00 amRNSNotice of Results and Investor Presentation
4th Aug 20227:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 202210:52 amRNSDirector/PDMR Dealing
1st Aug 20229:30 amRNSBlock Admission Interim Review
27th Jul 20227:00 amRNSFramework Agreement with MSC Shipmanagement
21st Jul 20224:41 pmRNSSecond Price Monitoring Extn
21st Jul 20224:35 pmRNSPrice Monitoring Extension
15th Jul 20225:40 pmRNSHolding(s) in Company
16th Jun 20227:00 amRNSIssue of Warrants
13th Jun 20227:30 amRNSMaterial Transfer & Cooperation Agreement
13th Jun 20227:00 amRNSAddendum to Representation Agreement
9th May 20227:00 amRNSOperational Update
22nd Apr 20224:40 pmRNSSecond Price Monitoring Extn
22nd Apr 20224:35 pmRNSPrice Monitoring Extension
11th Apr 20224:41 pmRNSSecond Price Monitoring Extn
11th Apr 20224:35 pmRNSPrice Monitoring Extension
11th Apr 20228:28 amRNSCommercial Development Agreement with Valkor
28th Mar 20227:00 amRNSInterim Results
1st Feb 20223:00 pmRNSBlock Admission Interim Review
1st Feb 20228:44 amRNSReplacement:Appointment of Non-Executive Chairman
1st Feb 20227:00 amRNSAppointment of Non-Executive Chairman
31st Jan 20227:00 amRNSUpdate re bioMSAR Testing at Aquafuel Research Ltd
27th Jan 202211:57 amRNSHolding(s) in Company
17th Jan 20224:41 pmRNSSecond Price Monitoring Extn
17th Jan 20224:35 pmRNSPrice Monitoring Extension
6th Jan 20224:41 pmRNSSecond Price Monitoring Extn
6th Jan 20224:36 pmRNSPrice Monitoring Extension
4th Jan 20227:00 amRNSAppointment of Chief Operating Officer
29th Dec 20214:42 pmRNSSecond Price Monitoring Extn
29th Dec 20214:36 pmRNSPrice Monitoring Extension
21st Dec 20214:41 pmRNSSecond Price Monitoring Extn
21st Dec 20214:36 pmRNSPrice Monitoring Extension
15th Dec 20215:05 pmRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.